Dr. Eric Matthew Zavaleta, MD

Dr. Zavaleta practices at Abilene Surgery Center in Abilene, Texas.

Dr. Zavaleta's NPI, 1619141363, was assigned on April 14, 2008. Dr. Zavaleta graduated from Texas A&M College of Medicine - Bryan in 2007. Dr. Zavaleta's Texas license number on file is N1239.

Dr. Zavaleta's primary practice is Abilene Surgery Center, at 5601 Health Center Drive, Abilene, TX 79606. The practice phone is (325) 690-4466.

Dr. Zavaleta's primary practice is Abilene Surgery Center in Abilene, Texas. Dr. Zavaleta is also affiliated with Hendrick Medical Center. Dmand AI also links Dr. Zavaleta to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zavaleta practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Zavaleta's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Zavaleta is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Zavaleta's licenses on file in 2 states: Texas and Alabama.

Dmand AI lists age-related macular degeneration, cataract, eyelid inflammation, glaucoma, glaucoma surgery, hereditary corneal conditions, hypertensive retinopathy and inflammation of iris among the conditions Dr. Zavaleta treats.

CMS data shows 19,898 Medicare services from Dr. Zavaleta across 20 procedure codes in 2024, for 1,230 Medicare patients. Medicare paid $2,379,362 for them.

CMS counts 1,230 Medicare patients who saw Dr. Zavaleta in 2024. The largest group is 65 to 74, with 450 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zavaleta's median patient age at 76, with 57% women.

In 2024, Dr. Zavaleta wrote 918 Medicare Part D claims for 223 patients. 73% of them were for generic drugs. CMS names the drug for 845 of them, across 14 drugs with 11 or more claims each, at $17,297 in total drug cost. In 2023, CMS named 772 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Zavaleta for performance year 2024, reported as part of a group. Dr. Zavaleta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of cataract surgery by Dr. Zavaleta, more than 32% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Zavaleta in 2020. The most frequent topics are Angiogenesis Inhibitors, Intravitreal Injections and Tomography, Optical Coherence. Dr. Zavaleta's most frequent co-authors are Mark Rami Barakat, MD, Thomas Anthony Ciulla, MD and Charles Leroy Clark, MD.

CMS Open Payments shows 38 general payments to Dr. Zavaleta from 14 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 91% of the total. Genentech, Inc. paid the most, $253.

Dr. Zavaleta graduated from Texas A&M College of Medicine - Bryan in 2007.

Dr. Zavaleta is in network with 23 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.